부산대학교 도서관

van Elsas MJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.; Middelburg J; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.; Labrie C; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.; Roelands J; Department of Pathology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.; Schaap G; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.; Sluijter M; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.; Tonea R; Department of Pathology, University of Chicago, Chicago, IL 60637, USA; Pritzker School of Molecular Engineering, Chicago, IL 60637, USA.; Ovcinnikovs V; Genmab, Utrecht 3584CT, the Netherlands.; Lloyd K; Genmab, Utrecht 3584CT, the Netherlands.; Schuurman J; Genmab, Utrecht 3584CT, the Netherlands.; Riesenfeld SJ; Pritzker School of Molecular Engineering, Chicago, IL 60637, USA.; Gajewski TF; Department of Pathology, University of Chicago, Chicago, IL 60637, USA.; de Miranda NFCC; Department of Pathology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.; van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.; van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden 2333ZA, the Netherlands. Electronic address: shvdburg@lumc.nl.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Ziblat A; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.; Horton BL; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.; Higgs EF; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.; Hatogai K; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.; Martinez A; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.; Shapiro JW; Center for Research Informatics, University of Chicago, Chicago, IL 60637, USA.; Kim DEC; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.; Zha Y; Human Immunological Monitoring Facility, University of Chicago, Chicago, IL 60637, USA.; Sweis RF; Department of Medicine, University of Chicago, Chicago, IL 60612, USA.; Gajewski TF; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA; Department of Medicine, University of Chicago, Chicago, IL 60612, USA. Electronic address: tgajewsk@bsd.uchicago.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Higgs EF; Gajewski TF

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Ferguson R; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; Departments of Population Health and Environmental Medicine, New York University-Grossman School of Medicine, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA.; Chat V; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; Departments of Population Health and Environmental Medicine, New York University-Grossman School of Medicine, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA.; Morales L; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; Departments of Population Health and Environmental Medicine, New York University-Grossman School of Medicine, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA.; Simpson D; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; Departments of Population Health and Environmental Medicine, New York University-Grossman School of Medicine, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA.; Monson KR; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; Departments of Population Health and Environmental Medicine, New York University-Grossman School of Medicine, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA.; Cohen E; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; Departments of Population Health and Environmental Medicine, New York University-Grossman School of Medicine, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA.; Zusin S; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; Departments of Population Health and Environmental Medicine, New York University-Grossman School of Medicine, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA.; Madonna G; Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Capone M; Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Simeone E; Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Pavlick A; Division of Hematology & Medical Oncology, the Cutaneous Oncology Program, Weill Cornell Medicine and New York-Presbyterian, New York, USA.; Luke JJ; Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA; UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.; Gajewski TF; Department of Pathology, University of Chicago, Chicago, IL, USA; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA; Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA.; Osman I; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA; Department of Medicine, New York University-Grossman School of Medicine, New York, NY, USA; Ronald O. Perelman Department of Dermatology, New York University-Grossman School of Medicine, New York, NY, USA.; Ascierto P; Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Weber J; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA; Department of Medicine, New York University-Grossman School of Medicine, New York, NY, USA.; Kirchhoff T; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA; Departments of Population Health and Environmental Medicine, New York University-Grossman School of Medicine, New York, NY, USA; The Interdisciplinary Melanoma Cooperative Group, New York University-Grossman School of Medicine, New York, NY, USA. Electronic address: Tomas.Kirchhoff@nyulangone.org.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. paolo.ascierto@gmail.com.; Agarwala SS; Temple University School of Medicine, Philadelphia, PA, USA.; Warner AB; Stanford University School of Medicine, Stanford, CA, USA.; Ernstoff MS; ImmunoOncology Branch (IOB), Developmental Therapeutics Program, Cancer Therapy and Diagnosis Division, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Fox BA; Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA.; Gajewski TF; Department of Pathology and Department of Medicine (Section of Hematology/Oncology), University of Chicago, Chicago, IL, USA.; Galon J; INSERM, Laboratory of Integrative Cancer Immunology, 75006, Paris, France.; Centre de Recherche Des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.; Equipe Labellisée Ligue Contre le Cancer, Paris, France.; Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.; Gastman BR; Department of Surgery, School of Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kalinski P; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Krogsgaard M; Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.; Leidner RS; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA.; Lo RS; Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.; Menzies AM; Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia.; Michielin O; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.; Poulikakos PI; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Weber JS; Laura and Isaac Perlmutter Cancer Center, a NCI-Funded Comprehensive Cancer Center, NYU School of Medicine, New York, NY, USA.; Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori 'Fondazione Pascale' IRCCS, Naples, Italy.; Osman I; Rudolf L, Baer, New York University Langone Medical Center, New York, NY, USA.; Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Thurin M; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institute of Health (NIH), Bethesda, MD, USA.

Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

Coveler AL; Fred Hutchinson Cancer Center, Seattle, Washington, USA acoveler@uw.edu.; University of Washington, Seattle, Washington, USA.; Smith DC; University of Michigan, Ann Arbor, Michigan, USA.; Phillips T; University of Michigan, Ann Arbor, Michigan, USA.; Curti BD; Providence Cancer Center, Portland, Oregon, USA.; Goel S; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.; Mehta AN; The University of Alabama, Birmingham, Alabama, USA.; Kuzel TM; Rush University Medical Center, Chicago, Illinois, USA.; Markovic SN; Mayo Clinic Minnesota, Rochester, Minnesota, USA.; Rixe O; The University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA.; Bajor DL; Case Western Reserve University, Cleveland, Ohio, USA.; University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.; Gajewski TF; The University of Chicago Medical Center, Chicago, Illinois, USA.; Gutierrez M; Hackensack University Medical Center, Hackensack, New Jersey, USA.; Lee HJ; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Gopal AK; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA.; Caimi P; Case Western Reserve University, Cleveland, Ohio, USA.; University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.; Heath EI; Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA.; Thompson JA; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA.; Ansari S; Seagen Inc, Bothell, Washington, USA.; Jacquemont C; Seagen Inc, Bothell, Washington, USA.; Topletz-Erickson A; Seagen Inc, Bothell, Washington, USA.; Zhou P; Seagen Inc, Bothell, Washington, USA.; Schmitt MW; Seagen Inc, Bothell, Washington, USA.; Grilley-Olson JE; Duke Cancer Institute, Durham, North Carolina, USA.; Duke University, Durham, North Carolina, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Mathias K; Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.; Rouhani S; Department of Medicine, Section of Hematology Oncology, Chicago, IL, USA.; Olson D; Department of Medicine, Section of Hematology Oncology, Chicago, IL, USA.; Bass AR; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, USA.; Gajewski TF; Department of Medicine, Section of Hematology Oncology, Chicago, IL, USA.; Committee on Clinical Pharmacology and Pharmacogenomics, Chicago, IL, USA.; Reid P; Committee on Clinical Pharmacology and Pharmacogenomics, Chicago, IL, USA.; Department of Medicine, Section of Rheumatology, University of Chicago Medical Center, Chicago, IL, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Reschke R; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.; Department of Dermatology and Venerology and Fleur Hiege-Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.; Gajewski TF; Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Higgs EF; Department of Pathology, The University of Chicago, Chicago, Illinois, USA.; Flood BA; Department of Pathology, The University of Chicago, Chicago, Illinois, USA.; Pyzer AR; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.; Rouhani SJ; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.; Trujillo JA; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.; Gajewski TF; Department of Pathology, The University of Chicago, Chicago, Illinois, USA.; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.; The Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois, USA.

Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 101507284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1947-5543 (Electronic) Linking ISSN: 19475543 NLM ISO Abbreviation: Biopreserv Biobank Subsets: MEDLINE

Chesney JA; UofL Health-Brown Cancer Center, University of Louisville, Louisville, KY.; Ribas A; Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, CA.; Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.; Kirkwood JM; UPMC Hillman Cancer Center, Pittsburgh, PA.; Dummer R; University Hospital of Zurich, Zurich, Switzerland.; Puzanov I; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Gajewski TF; University of Chicago Medical Center, Chicago, IL.; Gutzmer R; Medizinische Hochschule Hannover, Hannover, Germany.; Mühlenkreiskliniken Minden, Ruhr University Bochum, Bochum, Germany.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Demidov L; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.; Arenberger P; University Hospital Královské Vinohrady, Prague, Czech Republic.; Shin SJ; Division of Oncology, Yonsei University College of Medicine, Seoul, Korea.; Ferrucci PF; Biotherapy of Tumors Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.; Haydon A; Department of Medical Oncology, Alfred Hospital, Melbourne, Australia.; Hyngstrom J; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT.; van Thienen JV; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.; Guilera JM; Department of Dermatology, Barcelona University, Barcelona, IDIBAPS, CIBER de Enfermedades Raras ISCIII, Madrid, Spain.; Rapoport BL; The Medical Oncology Centre of Rosebank, Johannesburg, South Africa.; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.; VanderWalde A; Department of Hematology/Oncology, West Cancer Center & Research Institute, Memphis, TN.; Diede SJ; Merck & Co, Inc, Kenilworth, NJ.; Anderson JR; Merck & Co, Inc, Kenilworth, NJ.; Treichel S; Amgen Inc, South San Francisco, CA.; Chan EL; Amgen Inc, Thousand Oaks, CA.; Bhatta S; Amgen Inc, Thousand Oaks, CA.; Gansert J; Amgen Inc, Thousand Oaks, CA.; Hodi FS; Dana-Farber Cancer Institute, Boston, MA.; Gogas H; National and Kapodistrian University of Athens, Athens, Greece.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE